Danish Healthtech Stock News

Investors were disappointed with Shape Robotics A/S' ( CPH:SHAPE ) earnings, despite the strong profit numbers. We did...

Alefarm Brewing ( CPH:ALEFRM ) First Half 2025 Results Key Financial Results Revenue: kr.5.59m (up 18% from 1H 2024...

Brain+ ( CPH:BRAINP ) First Half 2025 Results Key Financial Results Net loss: kr.8.00m (flat on 1H 2024). We've found...

Despite posting some strong earnings, the market for Royal Unibrew A/S' ( CPH:RBREW ) stock hasn't moved much. We did...

Sydbank announced results for the half year ended June 30, 2025, reporting net interest income of DKK 1,930 million and net income of DKK 1,207 million, both lower than the previous year, while also completing a share buyback program totaling 1,138,104 shares for DKK 490 million. The bank also issued new profit after tax guidance for 2025, forecasting annual earnings between DKK 2,200 million and DKK 2,600 million, giving investors a fresh outlook for the year. With these updates, we'll...

Embla Medical hf.'s ( CPH:EMBLA ) price-to-earnings (or "P/E") ratio of 28.7x might make it look like a strong sell...

On August 26, 2025, Genmab announced that the U.S. FDA granted Breakthrough Therapy Designation to its investigational antibody-drug conjugate Rina-S for adult patients with recurrent or progressive endometrial cancer who progressed after prior platinum-based and PD-(L)1 therapies. This regulatory milestone spotlights Rina-S as a leading late-stage asset within Genmab's expanding oncology portfolio, reflecting the growing recognition of its promise in difficult-to-treat cancers. We'll...

ALK-Abelló A/S recently reported its second quarter and six-month 2025 earnings, highlighting sales growth to DKK 1,527 million and DKK 3,049 million respectively, with net income also rising compared to the previous year. This improved financial performance, including higher basic and diluted earnings per share from continuing operations, signals strengthened profitability and operational momentum during the reporting periods. With sales and earnings exceeding last year's results, we'll now...

At the recent European Society of Cardiology Congress in Madrid, Novo Nordisk presented results from the STEER real-world study showing that Wegovy® markedly reduced major cardiovascular events compared to tirzepatide among patients with obesity and established cardiovascular disease, but without diabetes. This new evidence, based on real-world patient data, strengthens Wegovy®’s position as a potentially differentiated treatment in the growing obesity and cardiometabolic space. We'll...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

There wouldn't be many who think Aktieselskabet Schouw & Co.'s ( CPH:SCHO ) price-to-earnings (or "P/E") ratio of 14.7x...

Investeringsselskabet Luxor ( CPH:LUXOR B ) Third Quarter 2025 Results Key Financial Results Revenue: kr.23.6m (down...

Key Insights Ørsted's estimated fair value is kr.359 based on 2 Stage Free Cash Flow to Equity Ørsted's kr.200 share...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

Hove A/S ( CPH:HOVE ) shareholders have had their patience rewarded with a 38% share price jump in the last month...

Per Aarsleff Holding ( CPH:PAAL B ) Third Quarter 2025 Results Key Financial Results Revenue: kr.5.75b (flat on 3Q...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

Amid concerns over the independence of the U.S. Federal Reserve and political uncertainties in Europe, the pan-European STOXX Europe 600 Index recently ended lower, reflecting broader market apprehensions. For investors looking beyond well-known stocks, penny stocks—often associated with smaller or newer companies—remain an intriguing area of exploration. Despite being considered a somewhat outdated term, these stocks can still offer compelling opportunities when backed by strong financials...

Investors were disappointed by MT Højgaard Holding A/S' ( CPH:MTHH ) latest earnings release. Our analysis has found...

Møns Bank ( CPH:MNBA ) Second Quarter 2025 Results Key Financial Results Revenue: kr.72.0m (up 3.4% from 2Q 2024). Net...

Key Insights Given the large stake in the stock by institutions, Alm. Brand's stock price might be vulnerable to their...

The fact that multiple Novo Nordisk A/S ( CPH:NOVO B ) insiders offloaded a considerable amount of shares over the past...